148 related articles for article (PubMed ID: 11081390)
21. Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice.
Sadanaga A; Nakashima H; Akahoshi M; Masutani K; Miyake K; Igawa T; Sugiyama N; Niiro H; Harada M
Arthritis Rheum; 2007 May; 56(5):1618-28. PubMed ID: 17469144
[TBL] [Abstract][Full Text] [Related]
22. Analyses of origin of synovial cells and repairing mechanisms of arthritis by allogeneic bone marrow transplantation.
Kitagawa H; Toki J; Inaba M; Sugiura K; Ogawa R; Ikehara S
Immunobiology; 1993 Jun; 188(1-2):99-112. PubMed ID: 8406562
[TBL] [Abstract][Full Text] [Related]
23. Enhancement of allogeneic hematopoietic stem cell engraftment and prevention of GVHD by intra-bone marrow bone marrow transplantation plus donor lymphocyte infusion.
Nakamura K; Inaba M; Sugiura K; Yoshimura T; Kwon AH; Kamiyama Y; Ikehara S
Stem Cells; 2004; 22(2):125-34. PubMed ID: 14990852
[TBL] [Abstract][Full Text] [Related]
24. Transplantation of umbilical cord mesenchymal stem cells alleviates lupus nephritis in MRL/lpr mice.
Gu Z; Akiyama K; Ma X; Zhang H; Feng X; Yao G; Hou Y; Lu L; Gilkeson GS; Silver RM; Zeng X; Shi S; Sun L
Lupus; 2010 Nov; 19(13):1502-14. PubMed ID: 20647254
[TBL] [Abstract][Full Text] [Related]
25. Prevention of diabetes in nonobese diabetic mice by nonmyeloablative allogeneic bone marrow transplantation.
Elkin G; Prigozhina TB; Slavin S
Exp Hematol; 2004 Jun; 32(6):579-84. PubMed ID: 15183899
[TBL] [Abstract][Full Text] [Related]
26. A new strategy for treatment of autoimmune diseases in chimeric resistant MRL/lpr mice.
Takeuchi K; Inaba M; Miyashima S; Ogawa R; Ikehara S
Blood; 1998 Jun; 91(12):4616-23. PubMed ID: 9616158
[TBL] [Abstract][Full Text] [Related]
27. Repeated 0.5-Gy gamma-ray irradiation attenuates autoimmune manifestations in MRL-lpr/lpr mice.
Tanaka T; Tago F; Fang SP; Shimura N; Kojima S
Int J Radiat Biol; 2005 Oct; 81(10):731-40. PubMed ID: 16449080
[TBL] [Abstract][Full Text] [Related]
28. Prevention of senile osteoporosis in SAMP6 mice by intrabone marrow injection of allogeneic bone marrow cells.
Ichioka N; Inaba M; Kushida T; Esumi T; Takahara K; Inaba K; Ogawa R; Iida H; Ikehara S
Stem Cells; 2002; 20(6):542-51. PubMed ID: 12456962
[TBL] [Abstract][Full Text] [Related]
29. New strategies for allogeneic BMT.
Ikehara S
Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S73-5. PubMed ID: 12931248
[TBL] [Abstract][Full Text] [Related]
30. IK cytokine ameliorates the progression of lupus nephritis in MRL/lpr mice.
Muraoka M; Hasegawa H; Kohno M; Inoue A; Miyazaki T; Terada M; Nose M; Yasukawa M
Arthritis Rheum; 2006 Nov; 54(11):3591-600. PubMed ID: 17075801
[TBL] [Abstract][Full Text] [Related]
31. Implication of allelic polymorphism of osteopontin in the development of lupus nephritis in MRL/lpr mice.
Miyazaki T; Ono M; Qu WM; Zhang MC; Mori S; Nakatsuru S; Nakamura Y; Sawasaki T; Endo Y; Nose M
Eur J Immunol; 2005 May; 35(5):1510-20. PubMed ID: 15832294
[TBL] [Abstract][Full Text] [Related]
32. [Combined mesenchymal stem cells and allogenic bone marrow transplantation in treatment of MRL/lpr mice].
Zhang GF; Zhang X; Dong GF
Zhonghua Nei Ke Za Zhi; 2008 Sep; 47(9):754-7. PubMed ID: 19080203
[TBL] [Abstract][Full Text] [Related]
33. Spironolactone blocks glucocorticoid-mediated hearing preservation in autoimmune mice.
Gross ND; Kempton JB; Trune DR
Laryngoscope; 2002 Feb; 112(2):298-303. PubMed ID: 11889387
[TBL] [Abstract][Full Text] [Related]
34. Expression of CD95 on mature leukocytes of MRL/lpr mice after transplantation of genetically modified bone marrow stem cells.
Federzoni E; Gordon G; Müller S; Schmid I; Simon HU; Yousefi S
Immunol Lett; 2008 Apr; 117(1):45-9. PubMed ID: 18222547
[TBL] [Abstract][Full Text] [Related]
35. Glucocorticoid impact on cochlear function and systemic side effects in autoimmune C3.MRL-Faslpr and normal C3H/HeJ mice.
Trune DR; Kempton JB; Harrison AR; Wobig JL
Hear Res; 2007 Apr; 226(1-2):209-17. PubMed ID: 17098384
[TBL] [Abstract][Full Text] [Related]
36. MRL/MP-lpr/lpr mouse as a model of immune-induced sensorineural hearing loss.
Kusakari C; Hozawa K; Koike S; Kyogoku M; Takasaka T
Ann Otol Rhinol Laryngol Suppl; 1992 Oct; 157():82-6. PubMed ID: 1416659
[TBL] [Abstract][Full Text] [Related]
37. Transfer of accelerated presbycusis by transplantation of bone marrow cells from senescence-accelerated mice.
Baba S; Iwai H; Inaba M; Kawamoto K; Omae M; Yamashita T; Ikehara S
Brain Res; 2006 Nov; 1120(1):93-9. PubMed ID: 17011530
[TBL] [Abstract][Full Text] [Related]
38. Anti-Ccl2 Spiegelmer permits 75% dose reduction of cyclophosphamide to control diffuse proliferative lupus nephritis and pneumonitis in MRL-Fas(lpr) mice.
Kulkarni O; Eulberg D; Selve N; Zöllner S; Allam R; Pawar RD; Pfeiffer S; Segerer S; Klussmann S; Anders HJ
J Pharmacol Exp Ther; 2009 Feb; 328(2):371-7. PubMed ID: 18997060
[TBL] [Abstract][Full Text] [Related]
39. Treatment of autoimmune diseases by hematopoietic stem cell transplantation.
Ikehara S
Exp Hematol; 2001 Jun; 29(6):661-9. PubMed ID: 11378260
[TBL] [Abstract][Full Text] [Related]
40. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
Steinmetz OM; Turner JE; Paust HJ; Lindner M; Peters A; Heiss K; Velden J; Hopfer H; Fehr S; Krieger T; Meyer-Schwesinger C; Meyer TN; Helmchen U; Mittrücker HW; Stahl RA; Panzer U
J Immunol; 2009 Oct; 183(7):4693-704. PubMed ID: 19734217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
